Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry  | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | Pfizer | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
| Ranbaxy | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
| Ranbaxy Laboratories | Sun Pharmaceuticals | pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $2,300,000 |
| Ranbaxy Pharmaceuticals, Inc. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
| Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
| Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $2,400,000 |
| Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
| Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
| Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
| Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
| Sandoz | Sandoz Group | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $16,000,000 |
| Sandoz | Sandoz Group | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $13,100,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $1,650,000 |
| Sandoz, Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
| Sanofi-Aventis | Sanofi | pharmaceuticals | consumer protection violation | 2019 | WV-AG | $1,600,000 |
| Sanofi-Aventis U.S. LLC | Sanofi | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $828,500 |
| Schering-Plough | Merck | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
| Schering-Plough | Merck | pharmaceuticals | False Claims Act and related | 2008 | MO-AG | $31,000,000 |
| Schering-Plough Corp. | Merck | pharmaceuticals | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
| Shering-Plough/Warrick Companies | Merck | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Shire | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
| SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
| SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
| Synthes, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2009 | NJ-AG | $236,000 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Takeda Pharmaceuticals | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
| Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
| TAP Pharmaceutical Products | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | AR-AG | $525,780 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | consumer protection violation | 2006 | ID-AG | $198,000 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | kickbacks and bribery | 2006 | KY-AG | $600,000 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | kickbacks and bribery | 2006 | WI-AG | $798,000 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
| Taro Pharmaceutical Industries | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
| Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
| Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
| TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
| Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
| Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2003 | MO-AG | $70,000 |
| Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
| Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
| Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
| Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
| Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
| UCB | UCB | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
| UCB Pharma, Inc. | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
| Warner Chilcott Holdings | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
| Warner-Lambert | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2004 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000 |
| Warrick Pharmaceuticals Corp. and Schering-Plough Corp. | Merck | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $750,000 |
| Warrick Pharmaceuticals Inc. | Merck | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $4,300,000 |
| Watson Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
| Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
| Watson, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
| Watson/Schein Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
| Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |
| Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |
| Abbott Laboratories | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $13,747,929 |
| AbbVie Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $13,747,929 |
| Aventis Pharmaceuticals | Sanofi | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $14,708,388 |
| Forest Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $7,089,034 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $49,505,368 |
| Novartis Pharmaceuticals | Novartis | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $21,280,356 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $41,047,101 |
| Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $18,960,210 |
| Takeda Pharmaceuticals U.S.A. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | MULTI-AG | $116,860,000 |
| Merck & Company, Inc. | Merck | pharmaceuticals | employment discrimination | 2019 | OFCCP | $289,755 |
| Mylan N.V. | Viatris | pharmaceuticals | investor protection violation | 2019 | SEC | $30,000,000 |
| Lupin Pharmaceuticals, Inc. | Lupin Limited | pharmaceuticals | False Claims Act and related | 2019 | TX-AG | $63,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2015 | CA-MULTI | $506,000 |
| Wyeth-Ayerst Laboratories Division | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
| Pfizer Pharmaceuticals, LLC | Pfizer | pharmaceuticals | air pollution violation | 2016 | EPA | $190,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
| Sigma Aldrich Co. | Merck KGaA (EMD) | pharmaceuticals | air pollution violation | 2004 | USAO | $180,000 |
| Baxalta US Inc. | Takeda Pharmaceutical | pharmaceuticals | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
| IDEXX Laboratories, Inc. | IDEXX Laboratories | pharmaceuticals | employment discrimination | 2020 | OFCCP | $200,000 |
| Apotex Corp. | Apotex Corp. | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2020 | WV-AG | $3,900,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
| Valeant Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | insurance violation | 2018 | CA-INS | $1,875,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | kickbacks and bribery | 2020 | CA-AG | $11,800,000 |
| Wockhardt USA | Wockhardt Limited | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2020 | CMS | $111,824 |
| DUSA Pharmaceuticals, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |
| Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | kickbacks and bribery | 2020 | MULTI-AG | $103,000,000 |
| Pacira Pharmaceuticals, Inc. | Pacira BioSciences | pharmaceuticals | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
| Boehringer Ingelheim Animal Health USA Inc. | Boehringer Ingelheim | pharmaceuticals | employment discrimination | 2020 | OFCCP | $379,089 |
| AbbVie Inc. | AbbVie | pharmaceuticals | consumer protection violation | 2020 | CA-INS | $24,000,000 |
| GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
| Merck & Co., Inc. | Merck | pharmaceuticals | tax violations | 2007 | IRS | $2,300,000,000 |
| MUTUAL PHARMACEUTICAL CO INC | Sun Pharmaceuticals | pharmaceuticals | environmental violation | 2012 | PA-ENV | $8,500 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2016 | PA-ENV | $6,943 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2003 | PA-ENV | $8,978 |
| SANOFI PASTEUR | Sanofi | pharmaceuticals | environmental violation | 2006 | PA-ENV | $28,620 |
| SANOFI PASTEUR | Sanofi | pharmaceuticals | environmental violation | 2007 | PA-ENV | $6,400 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2016 | PA-ENV | $14,906 |
